Report Detail

Other Global Bioreactor Perfusion Systems Market Insights, Forecast to 2025

  • RnM2975965
  • |
  • 20 February, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Other

The global Bioreactor Perfusion Systems market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bioreactor Perfusion Systems market based on company, product type, end user and key regions.

This report studies the global market size of Bioreactor Perfusion Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bioreactor Perfusion Systems in these regions.
This research report categorizes the global Bioreactor Perfusion Systems market by top players/brands, region, type and end user. This report also studies the global Bioreactor Perfusion Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Getinge AB (Sweden)
Medtronic plc (Ireland)
LivaNova PLC (U.K.)
Terumo Corporation (Japan)
XENIOS AG (Germany)
Lifeline Scientific, Inc. (U.S.)
XVIVO Perfusion AB (Sweden)
Repligen Corporation (U.S.)
Spectrum Laboratories, Inc. (U.S.)
Merck KGaA (Germany)
Harvard Bioscience, Inc. (U.S.)

Market size by Product
Heart-lung Machines
Perfusion Pumps
Oxygenators
Monitoring Systems
Cannulas
Others
Market size by End User
Hospital
Clinic
ASCs
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Bioreactor Perfusion Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bioreactor Perfusion Systems market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bioreactor Perfusion Systems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bioreactor Perfusion Systems submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bioreactor Perfusion Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bioreactor Perfusion Systems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Bioreactor Perfusion Systems Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Bioreactor Perfusion Systems Market Size Growth Rate by Product
      • 1.4.2 Heart-lung Machines
      • 1.4.3 Perfusion Pumps
      • 1.4.4 Oxygenators
      • 1.4.5 Monitoring Systems
      • 1.4.6 Cannulas
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Bioreactor Perfusion Systems Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 ASCs
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Bioreactor Perfusion Systems Market Size
      • 2.1.1 Global Bioreactor Perfusion Systems Revenue 2014-2025
      • 2.1.2 Global Bioreactor Perfusion Systems Sales 2014-2025
    • 2.2 Bioreactor Perfusion Systems Growth Rate by Regions
      • 2.2.1 Global Bioreactor Perfusion Systems Sales by Regions
      • 2.2.2 Global Bioreactor Perfusion Systems Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Bioreactor Perfusion Systems Sales by Manufacturers
      • 3.1.1 Bioreactor Perfusion Systems Sales by Manufacturers
      • 3.1.2 Bioreactor Perfusion Systems Sales Market Share by Manufacturers
      • 3.1.3 Global Bioreactor Perfusion Systems Market Concentration Ratio (CR5 and HHI)
    • 3.2 Bioreactor Perfusion Systems Revenue by Manufacturers
      • 3.2.1 Bioreactor Perfusion Systems Revenue by Manufacturers (2014-2019)
      • 3.2.2 Bioreactor Perfusion Systems Revenue Share by Manufacturers (2014-2019)
    • 3.3 Bioreactor Perfusion Systems Price by Manufacturers
    • 3.4 Bioreactor Perfusion Systems Manufacturing Base Distribution, Product Types
      • 3.4.1 Bioreactor Perfusion Systems Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Bioreactor Perfusion Systems Product Type
      • 3.4.3 Date of International Manufacturers Enter into Bioreactor Perfusion Systems Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Bioreactor Perfusion Systems Sales by Product
    • 4.2 Global Bioreactor Perfusion Systems Revenue by Product
    • 4.3 Bioreactor Perfusion Systems Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Bioreactor Perfusion Systems Breakdown Data by End User

    6 North America

    • 6.1 North America Bioreactor Perfusion Systems by Countries
      • 6.1.1 North America Bioreactor Perfusion Systems Sales by Countries
      • 6.1.2 North America Bioreactor Perfusion Systems Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Bioreactor Perfusion Systems by Product
    • 6.3 North America Bioreactor Perfusion Systems by End User

    7 Europe

    • 7.1 Europe Bioreactor Perfusion Systems by Countries
      • 7.1.1 Europe Bioreactor Perfusion Systems Sales by Countries
      • 7.1.2 Europe Bioreactor Perfusion Systems Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Bioreactor Perfusion Systems by Product
    • 7.3 Europe Bioreactor Perfusion Systems by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Bioreactor Perfusion Systems by Countries
      • 8.1.1 Asia Pacific Bioreactor Perfusion Systems Sales by Countries
      • 8.1.2 Asia Pacific Bioreactor Perfusion Systems Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Bioreactor Perfusion Systems by Product
    • 8.3 Asia Pacific Bioreactor Perfusion Systems by End User

    9 Central & South America

    • 9.1 Central & South America Bioreactor Perfusion Systems by Countries
      • 9.1.1 Central & South America Bioreactor Perfusion Systems Sales by Countries
      • 9.1.2 Central & South America Bioreactor Perfusion Systems Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Bioreactor Perfusion Systems by Product
    • 9.3 Central & South America Bioreactor Perfusion Systems by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Bioreactor Perfusion Systems by Countries
      • 10.1.1 Middle East and Africa Bioreactor Perfusion Systems Sales by Countries
      • 10.1.2 Middle East and Africa Bioreactor Perfusion Systems Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Bioreactor Perfusion Systems by Product
    • 10.3 Middle East and Africa Bioreactor Perfusion Systems by End User

    11 Company Profiles

    • 11.1 Getinge AB (Sweden)
      • 11.1.1 Getinge AB (Sweden) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Getinge AB (Sweden) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Getinge AB (Sweden) Bioreactor Perfusion Systems Products Offered
      • 11.1.5 Getinge AB (Sweden) Recent Development
    • 11.2 Medtronic plc (Ireland)
      • 11.2.1 Medtronic plc (Ireland) Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Medtronic plc (Ireland) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Medtronic plc (Ireland) Bioreactor Perfusion Systems Products Offered
      • 11.2.5 Medtronic plc (Ireland) Recent Development
    • 11.3 LivaNova PLC (U.K.)
      • 11.3.1 LivaNova PLC (U.K.) Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 LivaNova PLC (U.K.) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 LivaNova PLC (U.K.) Bioreactor Perfusion Systems Products Offered
      • 11.3.5 LivaNova PLC (U.K.) Recent Development
    • 11.4 Terumo Corporation (Japan)
      • 11.4.1 Terumo Corporation (Japan) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Terumo Corporation (Japan) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Terumo Corporation (Japan) Bioreactor Perfusion Systems Products Offered
      • 11.4.5 Terumo Corporation (Japan) Recent Development
    • 11.5 XENIOS AG (Germany)
      • 11.5.1 XENIOS AG (Germany) Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 XENIOS AG (Germany) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 XENIOS AG (Germany) Bioreactor Perfusion Systems Products Offered
      • 11.5.5 XENIOS AG (Germany) Recent Development
    • 11.6 Lifeline Scientific, Inc. (U.S.)
      • 11.6.1 Lifeline Scientific, Inc. (U.S.) Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Lifeline Scientific, Inc. (U.S.) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Lifeline Scientific, Inc. (U.S.) Bioreactor Perfusion Systems Products Offered
      • 11.6.5 Lifeline Scientific, Inc. (U.S.) Recent Development
    • 11.7 XVIVO Perfusion AB (Sweden)
      • 11.7.1 XVIVO Perfusion AB (Sweden) Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 XVIVO Perfusion AB (Sweden) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 XVIVO Perfusion AB (Sweden) Bioreactor Perfusion Systems Products Offered
      • 11.7.5 XVIVO Perfusion AB (Sweden) Recent Development
    • 11.8 Repligen Corporation (U.S.)
      • 11.8.1 Repligen Corporation (U.S.) Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Repligen Corporation (U.S.) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Repligen Corporation (U.S.) Bioreactor Perfusion Systems Products Offered
      • 11.8.5 Repligen Corporation (U.S.) Recent Development
    • 11.9 Spectrum Laboratories, Inc. (U.S.)
      • 11.9.1 Spectrum Laboratories, Inc. (U.S.) Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Spectrum Laboratories, Inc. (U.S.) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Spectrum Laboratories, Inc. (U.S.) Bioreactor Perfusion Systems Products Offered
      • 11.9.5 Spectrum Laboratories, Inc. (U.S.) Recent Development
    • 11.10 Merck KGaA (Germany)
      • 11.10.1 Merck KGaA (Germany) Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Merck KGaA (Germany) Bioreactor Perfusion Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Merck KGaA (Germany) Bioreactor Perfusion Systems Products Offered
      • 11.10.5 Merck KGaA (Germany) Recent Development
    • 11.11 Harvard Bioscience, Inc. (U.S.)

    12 Future Forecast

    • 12.1 Bioreactor Perfusion Systems Market Forecast by Regions
      • 12.1.1 Global Bioreactor Perfusion Systems Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Bioreactor Perfusion Systems Revenue Forecast by Regions 2019-2025
    • 12.2 Bioreactor Perfusion Systems Market Forecast by Product
      • 12.2.1 Global Bioreactor Perfusion Systems Sales Forecast by Product 2019-2025
      • 12.2.2 Global Bioreactor Perfusion Systems Revenue Forecast by Product 2019-2025
    • 12.3 Bioreactor Perfusion Systems Market Forecast by End User
    • 12.4 North America Bioreactor Perfusion Systems Forecast
    • 12.5 Europe Bioreactor Perfusion Systems Forecast
    • 12.6 Asia Pacific Bioreactor Perfusion Systems Forecast
    • 12.7 Central & South America Bioreactor Perfusion Systems Forecast
    • 12.8 Middle East and Africa Bioreactor Perfusion Systems Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Bioreactor Perfusion Systems Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Bioreactor Perfusion Systems . Industry analysis & Market Report on Bioreactor Perfusion Systems is a syndicated market report, published as Global Bioreactor Perfusion Systems Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Bioreactor Perfusion Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,905.30
      5,857.95
      7,810.60
      4,571.70
      6,857.55
      9,143.40
      765,674.00
      1,148,511.00
      1,531,348.00
      409,003.00
      613,504.50
      818,006.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report